Sold by: Next Move Strategy Consulting
Deployed on AWS
Get file-based Neuromodulation Devices Market research covering market sizing, segmentation, regional analysis, competitive benchmarking, and strategic developments. The market is estimated at USD 8.64 billion in 2025 and projected to reach USD 14.89 billion by 2030, growing at a CAGR of 11.5%.
Overview
Neuromodulation Devices Market Data Product Overview
The Neuromodulation Devices Market report covers market sizing and forecasts for 2025–2030, segmentation, regional analysis, competitive benchmarking, and company profiling. The market is estimated at USD 8.64 billion in 2025 and projected to reach USD 14.89 billion by 2030 at a CAGR of 11.5%. The report segments the market by component, product type, technology mode, power system, lead type, biomaterial, therapeutic application, end user, and region. Research combines primary interviews with industry experts and secondary research from proprietary databases and other secondary sources.
Use Cases
-
Market entry sizing: Assess the 2025 market estimate of USD 8.64 billion and the projected 2030 market value of USD 14.89 billion to support market entry and expansion planning.
-
Competitive benchmarking: Compare strategic developments and product innovations from 15 companies, including Medtronic, Abbott, and BrainsWay. M&A target screening: Evaluate opportunities across implantable and external devices, including applications involving deep brain stimulation and spinal cord stimulation.
-
Vendor evaluation: Compare market segments, regional coverage, end users, and technology modes across North America, Europe, Asia-Pacific, and Rest of the World.
Metadata
-
Update Frequency: One-time syndicated research product
-
Data Source(s): Primary interviews with industry experts + secondary research from proprietary databases and other secondary sources
-
Original Publisher of data: Next Move Strategy Consulting
-
Geographic coverage: North America, Europe, Asia-Pacific, and Rest of the World
-
Is historical data "point-in-time": Historical figures are point-in-time as of publication; forecast years are projections
-
Data Set(s) Format(s): PDF / Excel
-
Raw or scraped data: No, syndicated analyst research
-
Number of companies/brands covered: 15 Companies
Key Data Points
Rising prevalence of neurological disorders: The global number of brain disorder cases is projected to reach 4.9 billion by 2050, representing a 22% rise from 2021. Aging global population: The number of people aged 80 or over is projected to increase from 137 million in 2017 to 425 million by 2050, increasing demand for therapies addressing age-related neurological conditions. Growth in advanced neuromodulation solutions: The market is projected to grow from USD 8.64 billion in 2025 to USD 14.89 billion by 2030, reflecting a CAGR of 11.5%. Pricing Information
Next Move Strategy Consulting may offer different license tiers for this report, including single-user, multi-user, and enterprise options. Subscribers should inquire through the AWS Data Exchange offer for tier-specific pricing and terms.
Regulatory and Compliance Information
This report is built from aggregated, publicly available, and licensed secondary sources plus expert interviews conducted on an aggregated basis. It contains no individually identifiable personal data.
Subscription Verification
AWS Data Exchange requires subscription verification on all public offers. Subscribers confirm that they are not in a restricted country or a covered party.
About Your Company
Next Move Strategy Consulting (NextMSC) is a Boston-based market research and management consulting firm producing syndicated and custom research across healthcare and life sciences and other sectors, combining primary expert interviews with secondary research from proprietary databases. Learn more at nextmsc.com.
Highlights
- The Neuromodulation Devices Market is estimated at USD 8.64 billion in 2025 and projected to reach USD 14.89 billion by 2030, representing a CAGR of 11.5%. The dataset supports market sizing, forecast analysis, segmentation, regional assessment, and strategic planning for healthcare and life sciences organizations evaluating neuromodulation opportunities.
- The report tracks market drivers linked to the rising prevalence of neurological disorders, population aging, and growing acceptance of advanced neuromodulation therapies. It also examines cost-related adoption constraints and the emerging opportunity created by artificial intelligence integration for personalized and adaptive neuromodulation therapies.
- The file-based product covers North America, Europe, Asia-Pacific, and Rest of the World and provides segmentation by component, product type, technology mode, power system, lead type, biomaterial, therapeutic application, and end user. Competitive coverage includes 15 companies and documented product and technology developments across the market.
Details
Categories
Delivery method
Deployed on AWS
New
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Features and programs
Financing for AWS Marketplace purchases
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
Pricing
Custom pricing options
Pricing is based on your specific requirements and eligibility. Sign in to view any offers that have been extended to you.
Legal
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Additional details
You will receive access to the following data sets.
Data set name | Type | Historical revisions | Future revisions | Sensitive information | Data dictionaries | Data samples |
|---|---|---|---|---|---|---|
NMSC_MarketResearch | All historical revisions | All future revisions | Not included | Not included | ||
Food & Beverage Market Analytics | All historical revisions | All future revisions | Not included | Not included |
Similar products
The forecast for the global Neuromodulation Market indicates it is poised to reach $22 Billion by 2030, with a Compound Annual Growth Rate (CAGR) of 13% from 2023 to 2030. The rising incidence of neurological disorders worldwide is driving the need for enhanced healthcare infrastructure and innovative treatment methods for managing such conditions. Consequently, this surge in demand is fueling the expansion of the global neuromodulation market.
Access file-based nanomedicine market research covering market sizing, forecasts, segmentation, regional analysis, and competitive insights. The market is projected to reach USD 459.83 billion by 2030, growing at a CAGR of 11.9% from 2025 to 2030.
The Pain Management Devices Market represents a vital sector in healthcare innovation projected to expand from USD 7.57 billion in 2025 to USD 12.07 billion by 2030 at a compound annual growth rate of 9.78 percent. This growth is propelled by the rising incidence of chronic diseases an aging global population and advancements in artificial intelligence integrated therapies.
Access global pediatric medical devices market sizing, segmentation, competitive analysis, and forecasts, with the market projected to reach USD 58.24 billion by 2030 at a CAGR of 8.3% from 2025-2030. Coverage includes product type, age group, end-user, and regional analysis.